- Research article
- Open Access
Microbial fingerprinting detects intestinal microbiota dysbiosis in Zebrafish models with chemically-induced enterocolitis
© He et al.; licensee BioMed Central Ltd. 2013
- Received: 6 May 2013
- Accepted: 16 October 2013
- Published: 11 December 2013
Inflammatory bowel disease (IBD) involves a breakdown in interactions between the host immune response and the resident commensal microbiota. Recent studies have suggested gut physiology and pathology relevant to human IBD can be rapidly modeled in zebrafish larvae. The aim of this study was to investigate the dysbiosis of intestinal microbiota in zebrafish models with IBD-like enterocolitis using culture-independent techniques.
IBD-like enterocolitis was induced by exposing larval zebrafish to trinitrobenzenesulfonic acid (TNBS). Pathology was assessed by histology and immunofluorescence. Changes in intestinal microbiota were evaluated by denaturing gradient gel electrophoresis (DGGE) and the predominant bacterial composition was determined with DNA sequencing and BLAST and confirmed by real-time polymerase chain reaction. Larval zebrafish exposed to TNBS displayed intestinal-fold architecture disruption and inflammation reminiscent of human IBD. In this study, we defined a reduced biodiversity of gut bacterial community in TNBS-induced coliitis. The intestinal microbiota dysbiosis in zebrafish larvae with IBD-like colitis was characterized by an increased proportion of Proteobacteria (especially Burkholderia) and a decreased of Firmicutes(Lactobacillus group), which were significantly correlated with enterocolitis severity(Pearson correlation p < 0.01).
This is the first description of intestinal microbiota dysbiosis in zebrafish IBD-like models, and these changes correlate with TNBS-induced enterocolitis. Prevention or reversal of this dysbiosis may be a viable option for reducing the incidence and severity of human IBD.
- Denaturing gradient gel electrophoresis
- Trinitrobenzenesulfonic acid
Inflammatory bowel disease (IBD), broadly classified into ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic gastrointestinal (GI) illness of uncertain etiology with high morbidity and relapse. Symptoms range from abdominal pain, weight loss and diarrhea to ulceration, perforation and complete obstruction of the GI tract. Although the precise etiology of IBD remains unclear, several factors are believed to play a role in its development and progression, including host genotype, immune disequilibrium, the composition of microbial communities resident in the GI tract and environmental factors [1, 2]. In particular, the interactions between intestinal epithelial damage and microbial incursion have become new research hotspots.
The human intestinal tract plays host to approximately 100 trillion microorganisms, with at least 15,000-36,000 bacterial species. The intestinal microbiota is now considered to be a functional organ associated with normal physiological processes, such as metabolism, immunological response and intestinal epithelium morphogenesis [3–5]. Thus, there are many areas of host health that can be compromised when the microbiota is drastically altered. IBD clearly involves a breakdown in interactions between the host immune response and the resident commensal microbiota. Several investigators have documented changes in the gut microbiota associated with IBD, especially a dramatically reduced diversity in the phylum Firmicutes and concomitant increase in Proteobacteria[6–8]. In humans, a therapeutic strategy called fecal bacteriotherapy involving transfer of fecal material from a healthy donor to an IBD patient has successfully ameliorated the disease [9, 10]. That the restoration of microbial diversity is effective suggests the intestinal microbiota alteration may play a key role in disease pathogenesis. However, our knowledge of the microbiota shifts associated with IBD is far from complete, and it remains a question whether these changes are responsible for the origin of IBD, or alternatively, a direct or indirect consequence.
Murine models, for example, IL-10 deficient (IL-10−/−) mice and dextran sodium sulfate (DSS)-treated mice, have contributed enormously to understand the pathogenesis of IBD. Previous reports on DSS-induced colitis in murine models revealed that oral DSS-induced mucosal injury is more extensive in animals with commensal bacterial depletion compared to conventionalize counterparts. Contradictory data was seen in IL-10 deficient (IL-10−/−) mice, showing that IL-10−/− mice fail to develop spontaneous colitis if reared in germ-free conditions [11–13]. The difference may be caused by a variety of pathogenic mechanism, however, the research is limited by the time, cost and ethics and a new animal model is in badly need. The zebrafish model as an established developmental biology model has recently come to the fore in the study of developmental biology and disease processes. Fleming et al. developed an IBD-like model in zebrafish larvae using 2, 4, 6-trinitrobenzenesulfonic acid (TNBS), which enable study of host-bacterial interactions in detail in IBD processes [14, 15]. The zebrafish digestive tract is similar to that of mammals in its development, organization and function, and observation of the larvae gut following induction of IBD reveals region specific disease changes with biological, pathological and clinical relevance to the human condition [14–17]. Additionally, the zebrafish environment is relatively easy to manipulate and embryos can conveniently be produced in large numbers. Finally, the intestines of the zebrafish can be embedded in whole for analysis.
Zebrafish are well suited for studying host-bacterial interactions as they have innate and adaptive immune systems similar to higher vertebrates . Comparative metagenomic profiling of zebrafish and mouse gut microbiota revealed that they share six bacterial divisions, including Proteobacteria, Firmicutes, Bacteroidetes, Verrucomicrobia, Actinobacteria and Planctomycetes divisions . Besides, microarray analysis of gnotobiotic zebrafish has revealed transcriptional alterations in response to the microbiota that consistent with mammals, demonstrating an evolutionarily conserved role of the gut microbiota in vertebrate development [20, 21]. Moreover, the resident commensal microbiota in both fish and mice provide similar functions in the gut: they ferment polysaccharides to short-chain fatty acids (SCFAs) and play an important role in defense against pathogenic infection [21, 22]. In addition, studies in zebrafish gut differentiation show that in the absence of microbiota, the larvae gut is arrested in specific aspects of differentiation and altered in specific aspects of its function, which can be reversed by the introduction of bacteria later in development . Another study revealed alterations on gut microbiota after feeding the zebrafish dietary probiotic Lactobacillus rhamnosus for 10 days, which has significant effects on the reproductive physiology . All of this suggests that the microbiota in zebrafish gut may play the same role in disease pathogenesis as in mammals.
The aim of the work reported here was to carry out a molecular analysis on the composition of the intestinal microbiota in zebrafish larvae with TNBS-induced IBD-like colitis applying PCR-denaturing gradient gel electrophoresis (DGGE). A range of TNBS doses and exposure times were investigated in order to find out whether the intestinal epithelial damage and microbiota alternations in colitis processes are dose and time dependent fashion. Furthermore, we aimed to identify specific bacterial species of the gut microbiota that could be associated with the pathogenesis of colitis in zebrafish by DNA sequence analysis. Consequently, we also revealed the establishment of the resident microbiota in larval zebrafish gut from individuals of developing fish from 4 dpf to 8 dpf. Within the present work, we analyzed the zebrafish TNBS-induced enterocolitis in greater detail and first defined the changes of the intestinal microbiota in zebrafish IBD-like models, which might provide novel knowledge on the role of intestinal bacterial dysbiosis in IBD pathogenesis and show technical feasibility of studying host-bacterial interactions in IBD processes.
Pathological changes in TNBS-induced enterocolitis
Enterocolitis score system for histology evaluation
Intestinal-fold architecture disruption
Goblet cell appearance
Impaired epithelial integrity
Expanded clefts/reduced projections
Expanded gut lumen
Increased in number
Increased in number and different in sizes
Severe morphological changes
Representative pictures of the statistically significant groups are shown in Figure 2B. In the intestine bulb, the epithelium of control samples was characterized by projections and clefts, whereas in TNBS-treated samples the epithelium appeared smooth and the lumen was expanded. In the mid-intestine region, higher numbers of goblet cells were observed in TNBS-exposed fish compared with controls. Histological analysis did not show epithelial architecture disruption in the posterior intestine of both control and TNBS-exposed groups. In addition, goblet cells were observed in the regions of intestinal bulb and posterior intestine of larvae exposed to TNBS, while the presence of goblet cells remained restricted to the mid-intestine in the control.
Inflammatory cytokine production in larvae exposed to TNBS
Shifts in intestinal microbiota during TNBS-induced inflammation
The PCR-DGGE fingerprints showed changes of the composition and diversity in gut microbiota of the twelve groups of fish (Figure 5A). The first eight lanes represent the DGGE profiles of control and TNBS-exposed fish harvested at 4 dpf, whereas the lanes 9 to 16 represent the profiles of fish at 6 dpf and the last twelve lanes are the profiles at 8 dpf. At each of the time point, the gel shows the DGGE profiles of 4 groups: control (F1-F2, S1-S2, E1-E3), 25 μg/ml TNBS-exposed (F3-F4, S3-S4, E4-E6), 50 μg/ml TNBS-exposed (F5-F6, S5-S6, E7-E9) and 75 μg/ml TNBS-exposed (F7-F8, S7-S8, E10-E12).
The dendrogram based on DGGE banding similarity patterns showed that samples from different time points were separated into three different clusters (Figure 5B), indicating the establishment of the gut microbiota during zebrafish development from 4 to 8 dpf. At 8 pdf, the microbial composition in the control and TNBS-exposed groups especially the 75 μg/ml TNBS-exposed group had a significant variation, whereas at 4 and 6 dpf, the community profiles were not clearly distinct. It revealed TNBS exposure resulted in intestinal microbiota alteration by 8 pdf.
Bacterial species associated with inflammatory disorder
The sequence analysis of DGGE bands from the zebrafish GI tract
GenBank accession no.
As shown in Figure 7A, the composition of the bacterial community in larvae digestive tract changed over time to become dominated by the bacterial phyla of Proteobacteria and Firmicutes. In particular, the proportions of Proteobacteria phylum, including Hydrocarboniphaga daqingensis (L11), Limnobacter sp. (L13), Comamonas sp. (L16), Salmonella sp. (L17) and Aeromonas caviae (L19), were dramatically increased from 4 dpf to 8 dpf (p<0.01).
Meanwhile, the significant alterations in the abundance of the 19 bacterial phylotypes between the TNBS-exposed groups and controls at 8 dpf were revealed (Figure 7B). The sections of Proteobacteria , such as Hydrocarboniphaga daqingensis(L11), Limnobacter sp. (L13), Citrobacter freundii (L14), Comamonas sp. (L16) and Salmonella sp. (L17), showed an increase in relative richness in the gut microbiota of zebrafish exposed to TNBS as comparison with the control group (p<0.01). However, Citrobacter werkmanii (L18) was less abundant in TNBS-exposed groups than in the control (p<0.05). In addition, Firmicutes bacteria consisting of Lactococcus plantarum (L6), and Streptococcus sp. (L9) were less present in TNBS-exposed fish (p<0.05).
Enterocolitis severity and TNF-α expression correlate with the composition in gut microbiota
In the same way, we generated the correlation between TNF-α expression and TNBS-induced alterations in of gut microbiota. It came to the same conclusion that TNF-α expression correlated with the density of Burkholderia and Lactobacillus group and intestinal microbiota diversity, separately (Figure 9C, D).
Phylogenetic analysis of the predominant bacteria
In the present study, we established a zebrafish model organism to mimic human IBD using TNBS originally described by Fleming et al. It is confirmed that gut physiology and pathology relevant to this human disease state can be rapidly modeled following TNBS exposure, including intestinal epithelial damage, increase in goblet cells, production of inflammatory cytokines and intestinal microbiota dysbiosis. From the histological assessment of damage severity in the gut it was apparent that all larvae from the healthy control group showed no overt features of enterocolitis, while larvae exposed to TNBS exhibited pathological features consistent with enterocolitis time- and dose- dependently. The results present a detailed characterization of the development of intestinal inflammation in TNBS-treated larval zebrafish and establish a basis for using zebrafish to explore unique bacterial communities involved in the pathogenesis of IBD.
The aim of this study was to characterize the intestinal microbiota dysbiosis in the gut of zebrafish with IBD induced by TNBS, and to identify individual bacterial species that contribute to these dysbiosis. It is widely believed that IBD involves a breakdown in relations between the host immune response and microbial population resident in the GI tract. Reduced richness or diversity of bacterial species has been reported widely in patients with ulcerative colitis and Crohn’s disease, as well as in animal models with IBD, which was consistent with our observation [6, 8]. It could be hypothesized that, from its gut microbial community composition, the healthy larvae may have been more likely to format a stable micro-ecosystem with the intestinal environment, the gut epithelium and the mucosal immune system, therefore, less susceptible of developing IBD. Most studies suggest that the gut microbiota is an important factor in the pathogenesis of IBD, however, little is known about the contributions of particular intestinal species to health and disease.
Recently, increasingly molecular profiling techniques are being employed for the detection and characterization of the unculturable bacteria in the human colon. Studies based on DGGE have shown a faecal microbiota dysbiosis signature associated with CD, characterised by a decreased presence of Faecalibacterium prausnitzii, Bifidobacterium adolescentis, Dialister invisus, an unknown Clostridium sp. and an increased presence of Ruminococcus gnavus. Others revealed that Bacteroides vulgatus, Bacteroides uniformis, and Parabacteroides sp. were more commonly present at higher levels in healthy controls than in UC or IBD patients . The changes of the intestinal microbiota in IBD patients were not only investigated in Western population, but also a research on the faecal bacterial dysbiosis in Chinese CD patients showing an increase of the richness γ-Proteobacteria (especially Escherichia coli and Shigella flexneri) and a reduced proportion of Bacteroides and Firmicutes. Such differences were also observed by others applying terminal restriction fragment length polymorphism (T-RFLP) and fluorescent in situ hybridization (FISH) [27–29]. In murine models of IBD, Bacteroidales (Bacteroides sp., Alistipes, Butyricimonas, Odoribacter, and Parabacteroides sp.) and Lactobacillus sp. were predominantly associated with the DSS-induced colitic and healthy rats, respectively . Obviously, there were significant differences between the experimental sets from which samples were sourced. This may be caused by many factors including genetics, variations in environmental conditions from different geographic locations, as well as the microbiological status of food and water. Despite these differences, most of the studies have shown an increase of some opportunistic pathogenic Proteobacteria and a decreased proportion of Firmicutes phylum in CD, UC, or IBD.
The role of the microbiota in the zebrafish larval TNBS model has not been previously described. Our results showed that the dominant bacterial species were altered in the larvae intestine with TNBS-induced IBD, which was characterized by an overrepresentation of Proteobacteria and a relative lack of Firmicutes phylum. We observed that Limnobacter sp., Comamonas sp. and Salmonella sp., major members of Proteobacteria, had a significantly elevated abundance and became to be dominant in the samples from TNBS-treated groups. This is consistent with previous reports in IBD, which suggests that the host-microbial interactions are evolutionarily conserved and bacterial communities within the zebrafish intestines contribute the same to IBD etiology as in mammals. This work thus highlights the potential use of zebrafish in the study of gut microbial contributions to the pathogenesis of IBD and also other intestinal disorders. In fact, the zebrafish has shown several unique advantages that make it superior to other animal model organisms for microbial investigation. To start with, the composition of the mucosal- and luminal-associated/faecal microbiota has been shown to be significantly different in human digestive tract [31, 32]. Some believe the mucosal-associated microbiota seems of a closer link to the disease process than the faecal microbiota, as IBD is a disorder of mucosal inflammation. For a better understanding, characterisation of the mucosal-associated bacteria is therefore required. However, investigations are limited due to the difficulties of sampling of mucosal biopsy from healthy people. Besides, there is no conclusion whether the mucosal- or luminal-associated microbiota represents the accurate composition of the microbiota from patients with IBD. In contrast, our samples contain both the luminal- and mucosal-associated microbiota of the entire GI tract, which could reveal a better picture of the intestinal microbiotal composition. Furthermore, there was significant inter-individual variation in gut bacterial composition among both healthy and IBD groups in either humans or animal models research. The high inter-individual variability may cause confusion whether the microbiota shifts owing to the disease or the lifestyle and environmental changes. Whereas in zebrafish models, as each sample contains about 20 larvae, the individual differences could be greatly eliminated and more focusing on the differences in microbial communities between IBD groups and the healthy control. Finally, although studies have indicated a role for the microbiota in IBD development, to further understand this relationship between microbiota and host immunity and its degradation in inflammatory disease of the intestine, the next step must surely involve signaling pathways and molecular mechanisms through which the host recognizes gut microbiota and stimulates inflammatory processes. Rodent studies indicate that initial recognition of microbiota in the extracellular environment occurs via pathogen-recognition receptors (PRRs), which recognize microbial-associated molecular patterns (MAMPs) [33, 34]. Some studies have shown that TLR4 knockout mice did not develop enterocolitis upon treatment with DSS and TLR4 antagonist antibody ameliorates inflammatory response in colitic mice [35, 36]. In addition, a meta-analysis revealed that genetic variations in TLR4 presented a statistically significant risk of developing CD and UC . It is reasonable to speculate that gut microbiota play a role in the development of IBD via TLR signaling pathways. In zebrafish models, reverse genetic analyses using target-selected mutagenesis or antisense morpholino oligonucleotides (MOs) provide additional means for identifying molecular mediators of host–bacterial relationships in the gut [38, 39]. The completion of the zebrafish genome will facilitate these approaches and many more recently studies show the feasibility of studying host–microbial interactions in genetically engineered zebrafish.
In summary, we represented for the first time the molecular characteristics of intestinal microbiota dysbiosis in larval zebrafish with TNBS-induced IBD-like colitis. The present study defined a reduced biodiversity of gut bacterial community in IBD-like colitis. The intestinal microbiota dysbiosis in zebrafish IBD-like models was characterized by an increase of Proteobacteria and a reduced proportion of Firmicutes. The major challenge here is elucidating whether alterations in the gut microbial composition represent cause, or consequence, of host inflammation and disease state in IBD. In deed, it could be hypothesize that the chemicals, eg, TNBS, oxazolone, or DSS, affect the microbiota composition and then alterations in the microbial community initiate mucosal immune-mediated inflammation via TLRs signaling pathways. It is possible that changes in gut microbial ecology are crucial determinants in the susceptibility to experimental enterocolitis. However, in the present study, we observed that the intestinal epithelial damage and the overproduction of inflammatory cytokine (TNF-α) appeared ahead of the intestinal microbiota shifts. This may suggest that the chemicals initiate inflammation and the progressive inflammatory damage to the host intestinal mucosa applies pressure on the intestinal microbiota that further shifts community structure. Or the host and the microbiota interact in both ways and there is a feedback loop that perpetuates the inflammation. In characterizing these changes in community structure and function, it may be possible to provide new clues into determining the aetiological mechanisms of IBD and alter these events to prevent or ameliorate the disease.
All experiments with zebrafish were performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocols were approved by the Institutional Animal Care and Use Committee of Model Animal Research Center, Nanjing University (MARC-AP#: QZ01), in accordance with the Guideline on the Humane Treatment of Laboratory Animals in China and the Regulations for the Administration of Affairs Concerning Experimental Animals.
Zebrafish maintenance and embryo collection
Wild-type (AB strain) zebrafish were reared at 28±0.5°C on a 14-h light/10-h dark cycle in a closed flow-through system in charcoal-filtered and fully aerated tap water according to standard procedures . The fish were fed with commercial flakes twice daily.
Zebrafish embryos were collected from spawning adults in groups of about 16 males and 8 females in tanks overnight. Spawning was induced in the morning shortly after the light was turned on. Collected embryos were maintained in embryo medium (13.7 mM NaCl, 0.54 mM KCl, 1.3 mM CaCl2, 1.0 mM MgSO4, 0.25 mM Na2H PO4, 0.44 mM KH2 PO4, 0.42 mM NaHCO3) at 28.5°C. At 4–5 hours post-fertilization (hpf), those embryos that had developed normally and reached the blastula stage were selected under a dissecting microscope for subsequent experiments.
Induction of IBD by TNBS exposure
A stock solution of 5% (w/v) 2, 4, 6-trinitrobenzenesulfonic acid (TNBS; Sigma, St Louis, USA) in embryo medium was used for the induction of IBD. Zebrafish from 3 days post fertilization (dpf) were randomly placed into groups of 15 larvae in 20 ml of exposure solution (embryo medium containing 0, 25, 50 and 75 μg/mL TNBS). The range of concentrations was selected based on previously ascertained range-finding studies and information from the available literatures [14, 15]. A 90% (v/v) water change was performed each day starting at 3 pdf when larvae hatch from their chorions. Samples were collected at 4, 6 and 8 days postfertilization (dpf).
Larval zebrafish from 4 dpf, 6 dpf and 8 dpf were anesthetized by immersion in 0.2 mg/ml 3-amino benzoic acid ethylester (MS222, Sigma). For histology, samples were fixed in Bouin’s Fixative overnight at 4°C and mounted in SeaPlaque 1% low-melting point agarose. Then samples were dehydrated through a standard series of alcohols and Histo-clear and embedded in paraffin. 5 μm sections were cut for staining with hematoxylin and eosin. Histological sections were imaged and photographed with an Olympus CX41 system microscope (Olympus USA, Center Valley, PA, USA) and the DS-5 M-L1 digital sight camera system (Nikon, Japan). The enterocolitis scores were quantified by an observer who was blinded to the prior treatment of the fish. And these data represent three independent experiments.
Detection of goblet cells using AB-PAS staining
For goblet cell quantification, 5-μm paraffin sections were prepared as described in the Methods and stained sequentially with 1% Alcian blue pH 2.5 for 15 min, 1% aqueous periodic acid for 10 min and Schiff’s reagent for 10–15 min. Using this method, goblet cells stain blue. The number of goblet cells was counted manually along the length of the gut from the intestinal bulb to the anus.
Larvae at 4 dpf, 6 dpf and 8 dpf were fixed in 4% paraformaldehyde overnight at 4°C. Fixed larvae were soaked in 30% sucrose until they sink, transferred to embedding chamber filled with OCT Compound (Sakura Finetek USA, Inc, Torrance, CA, USA), snapped frozen in liquid nitrogen and stored at −80°C.
For immunofluorescence, 5-μm frozen sections were cut and blocked with 1% bovine serum albumin prior to being incubated with anti-TNF-α(IN), Z-Fish™, Catalog No. 55383P (1:150, 100 μg/400 μl, AnaSpec, Fremont, CA) overnight at 4°C. Sections were washed in PBS and incubated with Alexa Fluor 488-conjugated anti-mouse secondary antibodies (1:150, Invitrogen, La Jolla, CA) for 30 minutes at 4°C, followed by counterstained with DAPI (1:500). Sections were imaged and photographed with Leica TCS SP5 confocal scanning microscope (Leica Microsystems, Heidelberg GmbH, Mannheim, Germany). The intensity of TNF-α immunofluorescence was quantified for each treatment group, with a minimum of 6 samples per group, using color threshold and area measurements with AnalySis software.
Microbial analysis by denaturing gradient gel electrophoresis (DGGE)
The DGGE analysis was carried out to identify the microbial community in the intestine and to study the potential changes between the different groups of zebrafish.
Extraction of DNA and PCR amplification
Bacterial DNA was extracted from pools of 20 zebrafish larvae using the QIAamp DNA Stool Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s protocol, and stored at −20°C until use.
PCR was performed on an Applied Biosysterm 2720 Thermal Cycler as a touchdown PCR. The hypervariable V3 region of the 16S ribosomal DNA gene was amplified using polymerase chain reaction (PCR) with forward primer (GC357f 5′CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCACGGGGGGATTACCGCGGCTGCTGG3′) and reverse primer (518r 5′CCTACGGGAGGCAGCAG3′). The PCR reaction mixtures consisted of 2 μl of extracted bacterial DNA, 5 μl of 10×PCR buffer, 1 μl of dNTP mixture (2.5 mM each), 1 μl of each primer (10 pM), 0.5 μl of Taq-Polymerase (5 U/μl) and sterile water to final volume of 50 μl. The cycling program was as follows: predenaturation at 94°C for 5 min, followed by 20 cycles of 94°C for 30 s, 65°C for 30 s decreased by 0.5°C for each cycle, and 68°C for 30 s, after which 10 additional cycles of 94°C for 30 s, 55°C for 30 s, and 68°C for 30 s were carried out, and a final extension at 68°C for 7 min, soak at 4°C.
Integrity of PCR products was determined by running agarose gel electrophoresis, and the quantity was determined using QubitTM fluorometer (Invitrogen, NY, USA).
Denaturing gradient gel electrophoresis
DGGE was performed on the PCR products from DNA samples using 16 cm × 16 cm ×1 mm gels with a DCode Universal Mutation Detection System (Bio-Rad, Hercules, CA). A 35-50% urea and formamide denaturing gradient and 8% polyacrylamide gel (37.5:1 acrylamide-bisacrylamide) were used. The gradient was prepared using the gradient delivery system (Bio-Rad), following the manufacturer’s protocol. A 100% denaturant solution contained 7 M urea and 40% formamide. Gels were run in 1×TAE (20 mM Tris, 10 mM acetate, 0.5 M EDTA, pH 7.4) at 60°C, first at 200 V for 10 minutes and then at 120 V for 7.5 hours. The resulting gels were stained with SYBR Green I (Invitrogen) for 30 min, visualized and photographed using the Gel Doc EQ system (Bio-Rad, USA). All gels were normalized using a reference sample with bands distributed throughout the whole gel.
Analysis of DGGE profile
Gel images were aligned using Adobe Photoshop CS5 by running common samples on both outer sides of each gel, to allow comparison of two gels in one profile. DGGE profiles were analysed using Quantity One software (version 4.6; Bio-Rad Laboratories, Hercules, CA). The lanes were identified, and their background intensities were removed using the rolling disk method described in the program. Then bands were detected automatically by the software, followed by manual correction if necessary, and they were matched at 0.5% tolerance level. The tolerance level is the minimum spacing that the matching model expects to find between unique bands, and it is expressed as a percentage of lane height. The relative quantity of bands is expressed as a proportion (%) relative to the sum of the intensities of all of the bands in the same lane. A similarity matrix was computed by comparing the profiles of lanes, and the percentage similarity was expressed as the Dice coefficient. The presence or absence of a band in a lane was considered. Identical profiles have a percentage similarity of 100. Unweighted pair group method using arithmetic averages (UPGMA) was used to compare the similarity of samples in a dendrogram. The general diversity of bacterial communities was calculated by generating Shannon’s index of diversity on quantitative information .
Sequencing of DGGE bands
Bands of interest from DGGE gels were excised and immersed in 20 μl of sterile water and left overnight at 4°C. 2 μl of eluted DNA from each band was used as template for PCR re-amplification with the forward primer (without GC clamp) (357f 5′- ATTACCGCGGCTGCTGG -3′) and the reverse primer (518r 5′-CCTACGGGAGGCAGCAG-3′). PCR was performed in a 50 μl reaction mixture including 2 μl of template DNA, 5 μl of 10×PCR buffer, 1 μl of dNTP mixture (2.5 mM each), 1 μl of each primer (10 pM), 0.5 μl of Taq-Polymerase (5 U/μl) and 39.5 μl sterile water. Amplification was performed under the following conditions: 94°C for 5 min, 20 cycles of 94°C for 30s, 65°C for 30s decreased by 0.5°C for each cycle, and 68°C for 30 s, additional 15 cycles of 94°C for 30 s, 55°C for 30 s, and 68°C for 30 s, with a final extension at 68°C for 7 min.
After the PCR products were purified (QIAquick PCR Purification Kit, QIAGEN) and quantified (Qubit fluorometer, Invitrogen), the sequence analysis of the products was carried out using the Sanger’s method on an ABI 3730 automated sequencing system. The sequences obtained were then aligned with NCBI GenBank databases using the BLAST tool. The phylogenetic tree was constructed using the MEGA 4.0 program in the method of neighbor-joining based on evolutionary distances.
Quantitative real-time PCR analysis
Bacterial species that characterize the predominant intestinal dysbiosis in zebrafish larvae with TNBS-induced enterocolities derived from the DGGE comparative analyses were quantified by quantitative PCR using the 7300 Real-Time PCR System (Applied Biosystems, USA). A reaction mixture (20 μl) consisted of 1 μl of DNA (10 ng), 0.4 μl of each primer, 10 μl 2×SYBR. The primers and probes based on 16S rRNA gene sequences were chosen to target total bacteria, Lactobacillus group, the dominant group of Firmicutes, Enterobacteriaceae family and Burkholderia species, the main Proteobacteria phylum in zebrafish gut. Total bacterial 16S rRNA gene copies were quantified with primers (Bact1369; 5′CGGTGAATACGTTCYCGG3′and Prok1492; 5′GGWTACCTTGTTACGACTT3′). PCR was performed with an initial denaturation step of 95°C for 3 min, followed by 40 cycles of 95°C for 15 s, 56°C for 30 s and 72°C for 30 s. Lactobacillus group were quantified using the combination of forward, (LAC1; 5′AGCAGTAGGGAATCTTCCA3′), and reverse primer, (Lab0677; 5′CACCGCTACACATGGAG3′) in a cycling program where after the initial denaturation 95°C for 3 min, 40 cycles were applied at 95°C for 30 s, and binding and extension at 60°C for 1 min. Primer (Eco1457F; 5′CATTGACGTTACCCGCAGAAGAAGC3′) combined with primer (Eco1652R; 5′CTCTACGAGACTCAAGCTTGC3′) were used for the quantification of Enterobacteriaceae family with the following conditions: an initial DNA denaturation step at 95°C for 5 min, followed by 40 cycles of denaturation at 95°C for 15 s, and primer annealing and extension at 72°C for 30 s. Burkholderia species were quantified using the forward primer (Burk3; 5′CTGCGAAAGCCGGAT3′) and the reverse primer (BurkR; 5′TGCCATACTCTAGCYYGC3′) with the following cycling conditions: predenaturation at 95°C for 4 min; 60 cycles of 94°C for 1 min, 62°C for 90 s decreased by 1°C for every fifth cycle, after which 25 additional cycles were carried out at 58°C, and 72°C for 2 min, and a final extension at 72°C for 10 min. Data analysis was proceeded with Sequence Detection Software version 1.6.3 ( Applied Biosystems). All reactions were performed in triplicate. Specific bacteria 16S rRNA gene amount was normalized to total bacteria 16S rRNA. Quantification values were represented as mean (SEM) log 16S rRNA gene copies per 10 ng of bacterial genomic DNA.
Biochemical measurements were performed at least in duplicate. Quantitative histological analyses were performed by a blinded scorer. Results are presented as mean ± standard error of the mean. Survival curve comparison calculations used the Gehan-Breslow-Wilcoxon test. Two-way anova was applied to analyze the data to understand the combined effect of the two factors - time and treatment. Bonferroni multiple comparison post hoc tests were used to find the significant differences between the means at a particular time point⁄treatment. Pearson correlation, α =0.05, was used to assess linear relationships between enterocolitis score/inflammatory cytokine expression level and intensity/diversity in gut microbiota. All statistical analyses were performed with Graph-Pad Prism version 5.0 (GraphPad Software, San Diego, CA), and the significant differences are reported at P < 0.05.
Nucleotide sequences accession number
The sequences of 16S rRNA gene obtained in this study have been deposited in the GenBank database (EMBL, U.K.) under accession numbers KF515539-KF515557.
This work was supported by the Key Project of National Natural Science Foundation in China (30830098), National Natural Science Foundation in China (81070375), National Basic Research Program (973 Program) in China (2009CB522405), National High-tech R&D Program (863 Program) of China (2012AA021007) and Scientific Research Fund in Jiangsu Province (BK2009317). We thank Prof. Qingshun Zhao providing the zebrafish and embryos.
- Loftus EV: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004, 126 (6): 1504-1517. 10.1053/j.gastro.2004.01.063.PubMedView ArticleGoogle Scholar
- Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998, 115 (1): 182-205. 10.1016/S0016-5085(98)70381-6.PubMedView ArticleGoogle Scholar
- Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007, 104 (34): 13780-13785. 10.1073/pnas.0706625104.PubMedPubMed CentralView ArticleGoogle Scholar
- Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology. 2009, 136 (1): 65-80. 10.1053/j.gastro.2008.10.080.PubMedPubMed CentralView ArticleGoogle Scholar
- Bates JM, Mittge E, Kuhlman J, Baden KN, Cheesman SE, Guillemin K: Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation. Dev Biol. 2006, 297 (2): 374-386. 10.1016/j.ydbio.2006.05.006.PubMedView ArticleGoogle Scholar
- Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, Zhu W, Sartor RB, Boedeker EC, Harpaz N, et al: Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011, 17 (1): 179-184. 10.1002/ibd.21339.PubMedView ArticleGoogle Scholar
- Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ: Differences between tissue-associated intestinal microfloras of patients with Crohn’s disease and ulcerative colitis. J Clin Microbiol. 2006, 44 (11): 4136-4141. 10.1128/JCM.01004-06.PubMedPubMed CentralView ArticleGoogle Scholar
- Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L: High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011, 11: 7-10.1186/1471-2180-11-7.PubMedPubMed CentralView ArticleGoogle Scholar
- Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S: Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol. 2004, 38 (6): 475-483. 10.1097/01.mcg.0000128988.13808.dc.PubMedView ArticleGoogle Scholar
- Kahn SA, Gorawara-Bhat R, Rubin DT: Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?. Inflamm Bowel Dis. 2012, 18 (4): 676-684. 10.1002/ibd.21775.PubMedPubMed CentralView ArticleGoogle Scholar
- Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB: Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998, 66 (11): 5224-5231.PubMedPubMed CentralGoogle Scholar
- Hudcovic T, Stepankova R, Cebra J, Tlaskalova-Hogenova H: The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol (Praha). 2001, 46 (6): 565-572. 10.1007/BF02818004.View ArticleGoogle Scholar
- Kitajima S, Morimoto M, Sagara E, Shimizu C, Ikeda Y: Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp Anim. 2001, 50 (5): 387-395. 10.1538/expanim.50.387.PubMedView ArticleGoogle Scholar
- Fleming A, Jankowski J, Goldsmith P: In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study. Inflamm Bowel Dis. 2010, 16 (7): 1162-1172. 10.1002/ibd.21200.PubMedView ArticleGoogle Scholar
- Oehlers SH, Flores MV, Okuda KS, Hall CJ, Crosier KE, Crosier PS: A chemical enterocolitis model in zebrafish larvae that is dependent on microbiota and responsive to pharmacological agents. Dev Dyn. 2011, 240 (1): 288-298. 10.1002/dvdy.22519.PubMedView ArticleGoogle Scholar
- Ng AN, de Jong-Curtain TA, Mawdsley DJ, White SJ, Shin J, Appel B, Dong PD, Stainier DY, Heath JK: Formation of the digestive system in zebrafish: III. Intestinal epithelium morphogenesis. Dev Biol. 2005, 286 (1): 114-135. 10.1016/j.ydbio.2005.07.013.PubMedView ArticleGoogle Scholar
- Wallace KN, Akhter S, Smith EM, Lorent K, Pack M: Intestinal growth and differentiation in zebrafish. Mech Dev. 2005, 122 (2): 157-173. 10.1016/j.mod.2004.10.009.PubMedView ArticleGoogle Scholar
- Trede NS, Langenau DM, Traver D, Look AT, Zon LI: The use of zebrafish to understand immunity. Immunity. 2004, 20 (4): 367-379. 10.1016/S1074-7613(04)00084-6.PubMedView ArticleGoogle Scholar
- Rawls JF, Mahowald MA, Ley RE, Gordon JI: Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell. 2006, 127 (2): 423-433. 10.1016/j.cell.2006.08.043.PubMedView ArticleGoogle Scholar
- Rawls JF, Samuel BS, Gordon JI: Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proc Natl Acad Sci U S A. 2004, 101 (13): 4596-4601. 10.1073/pnas.0400706101.PubMedPubMed CentralView ArticleGoogle Scholar
- Hooper LV, Midtvedt T, Gordon JI: How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr. 2002, 22: 283-307. 10.1146/annurev.nutr.22.011602.092259.PubMedView ArticleGoogle Scholar
- Horn M, Nussbaumerova M, Sanda M, Kovarova Z, Srba J, Franta Z, Sojka D, Bogyo M, Caffrey CR, Kopacek P, et al: Hemoglobin digestion in blood-feeding ticks: mapping a multipeptidase pathway by functional proteomics. Chem Biol. 2009, 16 (10): 1053-1063. 10.1016/j.chembiol.2009.09.009.PubMedPubMed CentralView ArticleGoogle Scholar
- Carnevali O, Avella MA, Gioacchini G: Effects of probiotic administration on zebrafish development and reproduction. Gen Comp Endocr. 2013, 188: 297-302.PubMedView ArticleGoogle Scholar
- Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S: Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut. 2011, 60 (5): 631-637. 10.1136/gut.2010.223263.PubMedView ArticleGoogle Scholar
- Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A: Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010, 10: 134-10.1186/1471-230X-10-134.PubMedPubMed CentralView ArticleGoogle Scholar
- Li Q, Wang C, Tang C, Li N, Li J: Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn’s disease. PloS one. 2012, 7 (4): e34939-10.1371/journal.pone.0034939.PubMedPubMed CentralView ArticleGoogle Scholar
- Dicksved J, Lindberg M, Rosenquist M, Enroth H, Jansson JK, Engstrand L: Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol. 2009, 58 (Pt 4): 509-516.PubMedView ArticleGoogle Scholar
- Sepehri S, Kotlowski R, Bernstein CN, Krause DO: Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis. 2007, 13 (6): 675-683. 10.1002/ibd.20101.PubMedView ArticleGoogle Scholar
- Mylonaki M, Rayment NB, Rampton DS, Hudspith BN, Brostoff J: Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis. 2005, 11 (5): 481-487. 10.1097/01.MIB.0000159663.62651.4f.PubMedView ArticleGoogle Scholar
- Samanta AK, Torok VA, Percy NJ, Abimosleh SM, Howarth GS: Microbial fingerprinting detects unique bacterial communities in the faecal microbiota of rats with experimentally-induced colitis. J Microbiol. 2012, 50 (2): 218-225. 10.1007/s12275-012-1362-8.PubMedView ArticleGoogle Scholar
- Lindsey JT, Smith JW, McClugage SG, Nichols RL: Effects of commonly used bowel preparations on the large bowel mucosal-associated and luminal microflora in the rat model. Dis Colon Rectum. 1990, 33 (7): 554-560. 10.1007/BF02052206.PubMedView ArticleGoogle Scholar
- Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y: Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2011, 301 (5): G799-G807. 10.1152/ajpgi.00154.2011.PubMedPubMed CentralView ArticleGoogle Scholar
- Ohkusa T, Yoshida T, Sato N, Watanabe S, Tajiri H, Okayasu I: Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. J Med Microbiol. 2009, 58 (Pt 5): 535-545.PubMedPubMed CentralView ArticleGoogle Scholar
- Wells JM, Rossi O, Meijerink M, van Baarlen P: Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A. 2011, 108 (Suppl 1): 4607-4614.PubMedPubMed CentralView ArticleGoogle Scholar
- Rakoff-Nahoum S, Hao L, Medzhitov R: Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity. 2006, 25 (2): 319-329. 10.1016/j.immuni.2006.06.010.PubMedView ArticleGoogle Scholar
- Ungaro R, Fukata M, Hsu D, Hernandez Y, Breglio K, Chen A, Xu R, Sotolongo J, Espana C, Zaias J, et al: A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol. 2009, 296 (6): G1167-G1179. 10.1152/ajpgi.90496.2008.PubMedPubMed CentralView ArticleGoogle Scholar
- Shen X, Shi R, Zhang H, Li K, Zhao Y, Zhang R: The Toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohn’s disease and ulcerative colitis: a meta-analysis. Digestion. 2010, 81 (2): 69-77. 10.1159/000260417.PubMedView ArticleGoogle Scholar
- Mayer AN, Fishman MC: Nil per os encodes a conserved RNA recognition motif protein required for morphogenesis and cytodifferentiation of digestive organs in zebrafish. Development. 2003, 130 (17): 3917-3928. 10.1242/dev.00600.PubMedView ArticleGoogle Scholar
- Nasevicius A, Ekker SC: Effective targeted gene ‘knockdown’ in zebrafish. Nat Genet. 2000, 26 (2): 216-220. 10.1038/79951.PubMedView ArticleGoogle Scholar
- Ohrndorf S, Fischer IU, Kellner H, Strunk J, Hartung W, Reiche B, Burmester GR, Walther M, Schmidt WA, Backhaus M: Reliability of the novel 7-joint ultrasound score (US7): results from an inter- and intra-observer study performed by rheumatologists. Arthritis Care Res (Hoboken). 2012, 64 (8): 1238-1243.Google Scholar
- Jiang H, Qu L, Li Y, Gu L, Shi Y, Zhang J, Zhu W, Li J: Bone marrow mesenchymal stem cells reduce intestinal ischemia/reperfusion injuries in rats. J Surg Res. 2011, 168 (1): 127-134. 10.1016/j.jss.2009.07.035.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.